Morgan Stanley affirmed its Overweight rating on Syndax Pharmaceuticals Inc. (Nasdaq: SNDX) sending the stock price soaring $3.00 to close at $13.58.
Syndax Pharmaceuticals rating affirmed
March 14, 2018 at 17:48 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|